Total Payments
$3,085
2024 Payments
$65.47
Companies
19
Transactions
50
Medicare Patients
5,351
Medicare Billing
$301,401
Payment Breakdown by Category
Food & Beverage$2,200 (71.3%)
Travel$673.85 (21.8%)
Education$128.01 (4.1%)
Other$83.38 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,200 | 43 | 71.3% |
| Travel and Lodging | $673.85 | 3 | 21.8% |
| Education | $128.01 | 3 | 4.1% |
| Grant | $83.38 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,170 | 9 | $0 (2023) |
| Abbott Laboratories | $321.87 | 5 | $0 (2023) |
| Amgen Inc. | $234.30 | 5 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $216.59 | 6 | $0 (2024) |
| Medtronic Vascular, Inc. | $199.68 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $155.82 | 3 | $0 (2023) |
| MEDICOMP INC | $144.47 | 3 | $0 (2023) |
| BIOTRONIK INC. | $106.31 | 2 | $0 (2021) |
| ABIOMED | $103.37 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $93.08 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.47 | 3 | Novartis Pharmaceuticals Corporation ($25.97) |
| 2023 | $314.50 | 8 | MEDICOMP INC ($144.47) |
| 2022 | $139.54 | 7 | Novartis Pharmaceuticals Corporation ($39.95) |
| 2021 | $330.29 | 9 | BIOTRONIK INC. ($106.31) |
| 2020 | $161.66 | 3 | Abbott Laboratories ($98.53) |
| 2019 | $291.85 | 6 | Amgen Inc. ($125.33) |
| 2018 | $323.91 | 3 | Abbott Laboratories ($128.63) |
| 2017 | $1,458 | 11 | BOSTON SCIENTIFIC CORPORATION ($1,059) |
All Payment Transactions
50 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Not Applicable | ||||||
| 02/15/2024 | Terumo Medical Corporation | ANGIO-SEAL (Device) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: VASCULAR ACCESS | ||||||
| 10/11/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2023 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $60.73 | General |
| Category: CARDIOLOGY | ||||||
| 05/18/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $69.92 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 05/15/2023 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $44.92 | General |
| Category: Vascular | ||||||
| 04/04/2023 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $48.60 | General |
| Category: CARDIOLOGY | ||||||
| 02/22/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.42 | General |
| Category: Cardiovascular | ||||||
| 01/26/2023 | MEDICOMP INC | TELEPATCH CARDIAC MONITOR (Device) | Food and Beverage | In-kind items and services | $35.14 | General |
| Category: CARDIOLOGY | ||||||
| 01/19/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: WATCHMAN_IC | ||||||
| 09/20/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Cardiology | ||||||
| 06/02/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/02/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/30/2022 | Abbott Laboratories | XIENCE SIERRA (Device) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Vascular | ||||||
| 11/17/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $76.80 | General |
| Category: Diabetes | ||||||
| 11/17/2021 | CORDIS US CORP. | MYNXGRIP (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardiovascular | ||||||
| 11/09/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/26/2021 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | Cash or cash equivalent | $24.35 | General |
| Category: WATCHMAN | ||||||
| 09/21/2021 | BIOTRONIK INC. | Rivacor (Device), BioMonitor, Solia | Education | In-kind items and services | $90.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/21/2021 | BIOTRONIK INC. | Rivacor (Device), Solia, BioMonitor | Education | In-kind items and services | $16.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/25/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $46.37 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,083 | 1,225 | $474,487 | $72,128 |
| 2022 | 14 | 1,278 | 1,534 | $547,544 | $74,795 |
| 2021 | 12 | 1,238 | 1,461 | $509,351 | $66,724 |
| 2020 | 15 | 1,752 | 2,148 | $407,536 | $87,753 |
Total Patients
5,351
Total Services
6,368
Medicare Billing
$301,401
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 227 | $96,451 | $23,339 | 24.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 220 | 225 | $174,494 | $12,999 | 7.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 82 | $32,554 | $8,444 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $34,668 | $6,889 | 19.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 60 | $31,980 | $6,775 | 21.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 44 | $12,144 | $3,013 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 35 | $10,350 | $2,383 | 23.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 318 | 345 | $11,040 | $2,370 | 21.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $10,864 | $2,101 | 19.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 30 | 30 | $50,512 | $1,945 | 3.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 36 | 36 | $2,792 | $643.68 | 23.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 20 | 23 | $2,300 | $505.77 | 22.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 36 | 36 | $1,864 | $426.96 | 22.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 14 | 14 | $2,474 | $295.82 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 119 | 190 | $81,095 | $19,301 | 23.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 208 | 211 | $169,590 | $12,653 | 7.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 58 | 97 | $38,509 | $8,516 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $35,310 | $7,491 | 21.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 33 | $25,608 | $5,663 | 22.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 563 | 684 | $21,888 | $4,897 | 22.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 16 | 16 | $45,976 | $4,046 | 8.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 44 | 44 | $83,600 | $2,937 | 3.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 45 | $12,319 | $2,679 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 39 | $11,388 | $2,515 | 22.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 21 | $10,874 | $2,484 | 22.8% |
About Dr. Louis Heller, MD
Dr. Louis Heller, MD is a Interventional Cardiology healthcare provider based in Kingston, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821084237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Louis Heller, MD has received a total of $3,085 in payments from pharmaceutical and medical device companies, with $65.47 received in 2024. These payments were reported across 50 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,200).
As a Medicare-enrolled provider, Heller has provided services to 5,351 Medicare beneficiaries, totaling 6,368 services with total Medicare billing of $301,401. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease, Interventional Cardiology
- Location Kingston, NY
- Active Since 09/21/2005
- Last Updated 01/03/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1821084237
Products in Payments
- WATCHMAN (Device) $1,053
- Repatha (Biological) $190.89
- ENTRESTO (Drug) $151.85
- TELEPATCH CARDIAC MONITOR (Device) $144.47
- ELIQUIS (Drug) $139.40
- AMPLATZER Occluders (Device) $128.63
- INTERSTIM (Device) $116.30
- Rivacor (Device) $106.31
- Impella (Device) $103.37
- Xience Sierra Coronary Stent (Device) $98.53
- XARELTO (Drug) $93.08
- JARDIANCE (Drug) $76.80
- LEQVIO (Drug) $64.74
- PRALUENT ALIROCUMAB INJECTION (Biological) $50.93
- Definity (Drug) $50.25
- VERQUVO (Drug) $46.99
- DIAMONDBACK CORONARY (Device) $44.92
- WATCHMAN DEVICE (Device) $30.09
- XIENCE SIERRA (Device) $25.01
- Confirm Rx (Device) $24.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.